Anteris Technologies Global vs IRADIMED
IRADIMED reported revenue of $84 million in fiscal 2025, 44.1 times Anteris Technologies Global's $2 million in fiscal 2025. Anteris Technologies Global's revenue fell 29.2% in its latest year, and IRADIMED's grew 14.4%. Anteris Technologies Global had an operating margin of -4908.2%, against 31.2% at IRADIMED. Free cash flow was −$80 million at Anteris Technologies Global and $17 million at IRADIMED.
Side by side
| Anteris Technologies Global | IRADIMED | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $2M | $84M |
| Revenue growth | −29.2% | 14.4% |
| Revenue growth a year, last 5 years | — | 21.5% |
| Gross margin | 70.3% | 76.8% |
| Operating margin | −4,908.2% | 31.2% |
| Net margin | −4,921.3% | 26.8% |
| Free cash flow | −$80M | $17M |
| Free cash flow margin | −4,169.2% | 20.5% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $15M |
| Change in diluted share count | 82.2% | 0.6% |
| Last close | $5.42 | $85.35 |
| P/E at the last close | — | 45.6× |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Anteris Technologies GlobalIRADIMED
Operating margin
Percent of revenue
Anteris Technologies GlobalIRADIMED
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Anteris Technologies GlobalIRADIMED
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Anteris Technologies Global and IRADIMED pages.